Market revenue in 2023 | USD 37.0 million |
Market revenue in 2030 | USD 46.3 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.95% in 2023. Horizon Databook has segmented the Saudi Arabia regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia is one of the biggest pharmaceutical markets in Middle East region with estimated healthcare expenditure of USD 35.9 billion in 2013. The biopharmaceutical market is expected to grow with advancements in technology and government initiatives to promote private healthcare.
The major cause of concern is shortage of healthcare professionals for which the government is planning to increase the budget for health and social welfare.
Advancements in technology, increase in prevalence of chronic diseases, and quicker regulatory approvals as compared to countries like China, India, & Brazil are expected to contribute to the growth of number of clinical trials conducted in the region, thereby increasing the demand for regulatory services in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account